Skip to main navigation Skip to search Skip to main content

Pharmacogenomics education in medical and pharmacy schools: Conclusions of a global survey

  • Nataša Karas Kuželički*
  • , Irena Prodan Žitnik
  • , David Gurwitz
  • , Adrian Llerena
  • , Ingolf Cascorbi
  • , Sofia Siest
  • , Maurizio Simmaco
  • , Marc Ansari
  • , Mario Pazzagli
  • , Chiara DI Resta
  • , Ivan Brandslund
  • , Matthias Schwab
  • , Pieter Vermeersch
  • , Jeantine E. Lunshof
  • , George Dedoussis
  • , Christodoulos S. Flordellis
  • , Uwe Fuhr
  • , Julia C. Stingl
  • , Ron H.N. Van Schaik
  • , Vangelis G. Manolopoulos
  • Janja Marc
*Corresponding author for this work
  • University of Ljubljana
  • Medical University Badajoz
  • Kiel University
  • Université de Lorraine
  • University of Rome La Sapienza
  • Onco-Hematology Unit
  • University of Geneva
  • Cansearch Research Laboratory
  • University of Florence
  • Vita-Salute San Raffaele University
  • Genomics Unit for Diagnosis of Human Genetics
  • IRCCS San Raffaele Scientific Institute
  • University of Southern Denmark
  • Department of Clinical Pharmacology
  • University of Tübingen
  • Robert Bosch Foundation
  • Department of Pharmacy and Biochemistry
  • Department of Laboratory Medicine
  • KU Leuven
  • University of Groningen
  • Harvard University
  • Massachusetts Institute of Technology
  • Harokopio University
  • University of Patras
  • Centre of Pharmacology
  • University of Cologne
  • University of Bonn
  • Erasmus University Rotterdam
  • European Society of Pharmacogenomics and Personalised Therapy
  • Laboratory of Pharmacology
  • Democritus University of Thrace

Research output: Contribution to journal › Article › peer-review

73 Scopus citations

Abstract

Aim: The need for pharmacogenomic education is becoming more and more urgent. Our aim was to evaluate the progress in pharmacogenomics education since then, and to put forward further recommendations. Methods: A survey was sent to 248 schools of medicine, pharmacy, nursing and health professions around the world. Results: The majority of the study programs (87%) include pharmacogenomics education, which is generally taught as part of the pharmacology curriculum. On average, educators and teachers have selected appropriate and highly relevant pharmacogenomics biomarkers to include in their teaching programs. Conclusions: Based on the results, we can conclude that the state of pharmacogenomics education at the surveyed universities has improved substantially since 2005.

Original languageEnglish
Pages (from-to)643-657
Number of pages15
JournalPharmacogenomics
Volume20
Issue number9
DOIs
StatePublished - 2019

Funding

FundersFunder number
European Commission Horizon 2020 UPGx
Robert Bosch Stiftung
ICEPHA Graduate School Tuebingen-Stuttgart
Horizon 2020 Framework Programme668353

    Keywords

    • education
    • global survey
    • medicine
    • pharmacogenomics
    • pharmacy
    • recommendations

    Fingerprint

    Dive into the research topics of 'Pharmacogenomics education in medical and pharmacy schools: Conclusions of a global survey'. Together they form a unique fingerprint.

    Cite this